| Similar Articles |
|---|
 |
The Motley Fool
February 12, 2004
Rich Smith |
Interpore's Bruised Interpore's stock may have gotten pounded, but it's a minor wound.   |
The Motley Fool
April 28, 2004
Glen Trematore |
Zimmer Makes a Family Proud Zimmer Holdings looks strong when compared with other orthopedic/medical device makers. |
The Motley Fool
December 21, 2005
Stephen D. Simpson |
Biomet Takes a Bum Knee Company excuses aside, a subpar quarter lends credence to the notion that orthopedics companies are still in a tough spot. Investors, take note. |
The Motley Fool
December 12, 2006
Matthew Crews |
Smith & Nephew, What's the Deal? A merger with Biomet would be good in many ways. But what's the right price? Investors, take note. |
The Motley Fool
November 6, 2006
Matthew Crews |
Smith & Nephew Is Hip to Growth The medical technology company is showing solid growth, but a possible acquisition is cause for concern. Investors, take note. |
The Motley Fool
March 20, 2006
Rich Smith |
Foolish Forecast: Biomet Flexes The bone specialist is due to release its fiscal third-quarter 2006 report tomorrow morning. Here's what investors need to know to make sense of it. |
The Motley Fool
March 22, 2005
Stephen D. Simpson |
Can Biomet Elbow the Competition? The No. 4 player in orthopedics looks to close the gap. No matter what valuation metric you want to look at, Biomet shares look expensive on an absolute basis. |
The Motley Fool
April 21, 2006
Stephen D. Simpson |
Stryker Strikes a Chord A solid quarter and generally positive guidance refuels investor enthusiasm. |
The Motley Fool
September 20, 2006
Ryan Fuhrmann |
Biomet's Aching Joints Biomet operates in the appealing medical device industry, but current growth trends are giving investors a headache. |
The Motley Fool
September 21, 2005
Stephen D. Simpson |
Can Biomet Stay Limber? Concerns about pricing have buffeted the orthopedic space and the No. 4 player in hips and knees. Whatever the case turns out to be, Biomet is probably a bit riskier than average. |
The Motley Fool
June 28, 2004
Rick Aristotle Munarriz |
Food for Fiscal Thought Food makers will open the cupboards this week to take stock of their quarterly earnings. |
The Motley Fool
April 24, 2007 |
Modest Biomet: Fool by Numbers The bone specialist released third-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
March 28, 2006
Stephen D. Simpson |
A Surprising Turn at Biomet The large orthopedic company replaces one of its founders. This change doesn't really make the stock dramatically more, or less, attractive than before. Investors, take note. |
The Motley Fool
September 25, 2006
Anders Bylund |
3 Stocks That Missed the Mark A peek at companies that over-promised and under-delivered: Biomet... A.G. Edwards... 3Com... |
The Motley Fool
June 30, 2005
Stephen D. Simpson |
Biomet Wants Your Body Steady growth continues at the #4 orthopedics player. But Biomet shares haven't had a great year so far, hovering close to their 52-week low. |
The Motley Fool
April 26, 2007
Tim Beyers |
Who's Filing Now? Take a look at what lurks in Friday's late filings. The Sharper Image... J. Crew... Biomet... etc. |
The Motley Fool
June 24, 2005
Rick Aristotle Munarriz |
The Fool's Look Ahead Monday: Nike's top line should continue to move higher... Tuesday: For years, investors in Apollo Group have been schooling the market... Wednesday: Even if you don't own shares of software giant Oracle, you should still tune in for its midweek earnings report... etc. |
The Motley Fool
January 10, 2005
W.D. Crotty |
This "dj" is Primed to Play Hits Medical device company dj Orthopedics reaps huge gains after a good sales report. |
The Motley Fool
January 31, 2006
Stephen D. Simpson |
Zimmer Muddles Through So long as the pressures in the orthopedic sector prove less than originally feared, investors could still make money here. |
